Product image of Kenacort-T (Triamcinolone Acetonide) supplied by GNH India

Kenacort-T

Active Ingredient:
Triamcinolone Acetonide
Origin:
EU

Kenacort-T (Triamcinolone Acetonide)

Triamcinolone Acetonide, the active ingredient in Kenacort‑T, is a corticosteroid (glucocorticoid) presented as an injectable solution for intra‑articular and intramuscular administration. It provides anti‑inflammatory and immunosuppressive effects that are used to manage rheumatoid arthritis, osteoarthritis, bursitis, synovitis and other inflammatory musculoskeletal disorders in adult patients.

GNH India supplies Kenacort‑T as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution, with reliable logistics and post‑sale support.

Manufacturer / TM Owner

Bristol-Myers Squibb Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kenacort‑T is a glucocorticoid injected directly into joints or muscle to control inflammation in musculoskeletal disease.

  • Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility.
  • Osteoarthritis: alleviates chronic joint swelling and stiffness.
  • Bursitis: decreases bursae inflammation, facilitating faster recovery.
  • Synovitis: suppresses synovial membrane inflammation, limiting joint damage.
  • General inflammatory musculoskeletal conditions: provides broad anti‑inflammatory action to control symptoms.

How It Works

  • Triamcinolone Acetonide binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This interaction up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, leading to reduced leukocyte migration, decreased capillary permeability, and overall suppression of the immune response at the site of injection.

Side Effects

Kenacort‑T may cause a range of adverse reactions, most of which are related to its corticosteroid activity.

Common Side Effects

  • Injection‑site pain or irritation.
  • Transient flushing or facial redness.
  • Mild headache.
  • Temporary increase in blood glucose levels.
  • Elevated blood pressure.
  • Mood changes or insomnia.

Serious or Rare Side Effects

  • Adrenal insufficiency or suppression.
  • Severe allergic reaction (anaphylaxis, angioedema).
  • Opportunistic infections or reactivation of latent infections.
  • Osteonecrosis of the jaw or long bones.
  • Significant hyperglycemia leading to diabetic complications.
  • Thromboembolic events.

Precautions & Warnings

Before using Kenacort‑T, clinicians should evaluate patient‑specific risk factors and follow safe handling practices.

  • Assess infection risk: screen for active or latent infections prior to injection.
  • Monitor glucose: check blood sugar in diabetic patients before and after administration.
  • Evaluate bone health: consider osteoporosis risk in long‑term users.
  • Review anticoagulant therapy: assess bleeding risk when combined with blood thinners.
  • Caution in pregnancy and lactation: weigh potential benefits against unknown fetal risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Kenacort‑T can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

  • Live vaccines: concurrent use may suppress vaccine efficacy and increase infection risk.
  • Systemic CYP3A4 inducers (e.g., rifampicin, phenytoin): may reduce corticosteroid exposure.
  • Anticoagulants (e.g., warfarin): increased risk of gastrointestinal bleeding.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive risk of gastric ulceration.
  • Diabetic agents: potential for exacerbated hyperglycemia.
  • Other immunosuppressants: heightened infection susceptibility.

Frequently Asked Questions

Kenacort‑T is an injectable formulation of triamcinolone acetonide used to treat inflammatory musculoskeletal disorders such as rheumatoid arthritis, osteoarthritis, bursitis, synovitis and other conditions where local anti‑inflammatory action is required.

Triamcinolone acetonide binds to glucocorticoid receptors inside cells, altering gene transcription. This results in increased production of anti‑inflammatory proteins and suppression of pro‑inflammatory cytokines, thereby reducing swelling, pain and immune activity at the injection site.

The specific dose of Kenacort‑T is determined by the prescribing clinician based on the indication, severity of disease, patient weight and response. Dosing regimens may vary from a single intra‑articular injection to repeated administrations as medically indicated.

Safety data for Kenacort‑T in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Kenacort‑T, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.

Kenacort‑T (triamcinolone acetonide) is a medium‑potency glucocorticoid with a relatively long duration of action when injected intra‑articularly or intramuscularly. Compared with lower‑potency agents like hydrocortisone, it provides stronger anti‑inflammatory effects, while higher‑potency steroids such as dexamethasone may have a faster onset but a shorter local residence time.

Kenacort‑T must be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze or shake the vial. Before use, allow the product to reach room temperature if required, and handle it with aseptic technique to maintain sterility.

Kenacort‑T is administered by a qualified healthcare professional as an intra‑articular or intramuscular injection. The injection site is prepared aseptically, and the dose is delivered using a sterile needle and syringe according to the prescriber’s instructions.

Serious risks include adrenal suppression, severe allergic reactions (anaphylaxis), opportunistic infections, osteonecrosis, and significant hyperglycemia. Patients should be monitored for signs of infection, unexplained fatigue, sudden mood changes, or abnormal blood glucose levels, and any severe reaction should prompt immediate medical attention.

Kenacort‑T is contraindicated in patients with known hypersensitivity to triamcinolone acetonide or any component of the formulation, those with active systemic infections, and individuals receiving live vaccines. Caution is also advised for patients with uncontrolled diabetes, severe osteoporosis, or a history of severe psychiatric disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Triamcinolone Acetonide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT